KR910700234A - 에난티오머적으로 순수한 다치환 1,4-디히드로피리딘류의 제조 방법 - Google Patents

에난티오머적으로 순수한 다치환 1,4-디히드로피리딘류의 제조 방법

Info

Publication number
KR910700234A
KR910700234A KR1019900702275A KR900702275A KR910700234A KR 910700234 A KR910700234 A KR 910700234A KR 1019900702275 A KR1019900702275 A KR 1019900702275A KR 900702275 A KR900702275 A KR 900702275A KR 910700234 A KR910700234 A KR 910700234A
Authority
KR
South Korea
Prior art keywords
dihydropyridines
enantiomerically pure
polysubstituted
racemic
give
Prior art date
Application number
KR1019900702275A
Other languages
English (en)
Other versions
KR0155557B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR910700234A publication Critical patent/KR910700234A/ko
Application granted granted Critical
Publication of KR0155557B1 publication Critical patent/KR0155557B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019900702275A 1989-02-17 1990-02-15 에난티오머적으로 순수한 다치환 1,4-디히드로피리딘류의 제조 방법 KR0155557B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT8919477A IT1230752B (it) 1989-02-17 1989-02-17 Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
IT19477A/89 1989-02-17
PCT/EP1990/000243 WO1990009376A1 (en) 1989-02-17 1990-02-15 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines

Publications (2)

Publication Number Publication Date
KR910700234A true KR910700234A (ko) 1991-03-14
KR0155557B1 KR0155557B1 (ko) 1998-11-16

Family

ID=11158352

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900702275A KR0155557B1 (ko) 1989-02-17 1990-02-15 에난티오머적으로 순수한 다치환 1,4-디히드로피리딘류의 제조 방법

Country Status (17)

Country Link
US (1) US5245039A (ko)
EP (2) EP0383320A1 (ko)
JP (1) JPH04505610A (ko)
KR (1) KR0155557B1 (ko)
AT (1) ATE95813T1 (ko)
AU (1) AU630928B2 (ko)
CA (1) CA2047741A1 (ko)
DE (1) DE69003936T2 (ko)
DK (1) DK0458823T3 (ko)
ES (1) ES2060144T3 (ko)
FI (1) FI95371C (ko)
HU (1) HUT62270A (ko)
IE (1) IE66498B1 (ko)
IT (1) IT1230752B (ko)
NO (1) NO177186C (ko)
RU (1) RU2069658C1 (ko)
WO (1) WO1990009376A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
JPH07501551A (ja) * 1991-12-02 1995-02-16 セプラコア,インコーポレーテッド 光学的に純粋なs(−)フェロジピンを用いる,高血圧,狭心症および他の疾患を治療するための方法および組成物
ES2055655B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isobutil-5-metil.
ES2055652B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2,3-diclorofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
ES2055653B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion del 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isopropil-5-(2-metoxi)etil.
ES2055654B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
FR2719585B1 (fr) * 1994-05-05 1996-08-02 Lafon Labor Procédé d'obtention de 1,4-dihydropyridines optiquement pures.
US5554621A (en) * 1995-06-07 1996-09-10 Bristol-Myers Squibb Company Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
ITMI20012434A1 (it) 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
WO1988007531A1 (en) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh New optically active compounds
JP2625190B2 (ja) * 1987-03-27 1997-07-02 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 1,4―ジヒドロピリジン―エナンチオマーおよびその製法

Also Published As

Publication number Publication date
RU2069658C1 (ru) 1996-11-27
FI913861A0 (fi) 1991-08-15
EP0383320A1 (en) 1990-08-22
EP0458823B1 (en) 1993-10-13
KR0155557B1 (ko) 1998-11-16
IE66498B1 (en) 1996-01-10
IE900584L (en) 1990-08-17
IT8919477A0 (it) 1989-02-17
JPH04505610A (ja) 1992-10-01
NO913188D0 (no) 1991-08-15
HUT62270A (en) 1993-04-28
CA2047741A1 (en) 1990-08-18
ATE95813T1 (de) 1993-10-15
US5245039A (en) 1993-09-14
EP0458823A1 (en) 1991-12-04
NO177186C (no) 1995-08-02
NO177186B (no) 1995-04-24
DE69003936T2 (de) 1994-03-31
FI95371C (fi) 1996-01-25
NO913188L (no) 1991-08-15
WO1990009376A1 (en) 1990-08-23
DE69003936D1 (de) 1993-11-18
DK0458823T3 (da) 1994-02-21
FI95371B (fi) 1995-10-13
ES2060144T3 (es) 1994-11-16
AU5090490A (en) 1990-09-05
IT1230752B (it) 1991-10-29
AU630928B2 (en) 1992-11-12

Similar Documents

Publication Publication Date Title
KR910700234A (ko) 에난티오머적으로 순수한 다치환 1,4-디히드로피리딘류의 제조 방법
ATA55589A (de) Mikroorganismus der species bacillus coagulans sowie ein verfahren zur herstellung von optisch reiner l(+)-milchsaeure
DE3851070D1 (de) Verfahren zur Herstellung eines Oxid-Verbindungssupraleiterfadens.
PT89081A (pt) Processo para a producao de analogos do factor de crescimento de fibroblastos
PT92603A (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
DE3889398D1 (de) Verfahren zur Herstellung eines Supraleiters.
JPS6486898A (en) Method for manufacturing ibuprofen
ATE204283T1 (de) Verfahren zur herstellung von 2,2- difluorketensilylacetalen und alpha,alpha-difluor-beta -silyloxy-1,3-dioxolan-4-propansäureestern
DE69007599D1 (de) Verfahren zur Racemisierung optisch aktiver Carbonsäureester.
PT91006A (pt) Processo para a preparacao de um novo sal de estroncio
AT375940B (de) Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze
ATA75879A (de) Verfahren zur herstellung von neuen 1-naphthyl- essigsaeuren sowie deren estern, amiden und pharmazeutisch vertraeglichen salzen
DE69033833D1 (de) Verfahren zur Herstellung von Butantetracarbonsäure
ATE95244T1 (de) Verfahren zur herstellung von l-phosphinothricin.
AT373585B (de) Verfahren zur herstellung neuer, optisch aktiver oder racemischer 6,7-benzomorphan-derivate und deren saeureadditionssalze
FR2611708B1 (fr) Procede de production d'acides alcane-sulfoniques
FR2561643B1 (fr) Procede de production d'acide trifluoroacetique a partir de trichlorotrifluoroethane
ATE119899T1 (de) Verfahren zum herstellen von cyclischen kohlensäureestern.
ATA18878A (de) Verfahren zur herstellung von (1,1-dithienyl- -(3-propen-(1)-yl-(3))-(1-phenyl-1-hydroxyproyl -(2))-amin und dessen saeureadditionssalzen und optisch aktiven isomeren
DE3851942D1 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.
HUT61291A (en) Process for producing optically active quinoxalinyloxy phenoxypropionic acid esters
EP0104639A3 (en) Process for improving carbon fibers
DE68924482D1 (de) Verfahren zur herstellung optisch aktiver 2-hydroxy-4-phenyl-3-butensäure.
DE3885098D1 (de) Elektroenzymatisches verfahren zur herstellung von verbindungen mit kontrollierter enantiomerischer reinheit.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee